Design of combination therapeutics from protein response to drugs in ovarian cancer cells
High-grade serous ovarian cancer has an unmet clinical need High-grade serous ovarian cancer (HGSOC) is the most common and most aggressive subtype of ovarian cancer with a high mortality rate (Matulonis et al. 2016; Siegel, Miller, and Jemal 2019). …